Robert M. Insoft, MD, FAAP
Medical Director, NICU and Neonatal Respiratory Services
Assistant Professor, Harvard Medical School
Research Focus
- Quality improvement in the area of intra- and inter-facility transport of critically ill neonates
- Quality improvement in the delivery of care to critically ill neonates in the inpatient setting
- Development and utilization of innovative methods, including simulation, to teach medical trainees
Research Goals
To improve the efficiency of hospital systems that impact care to critically ill neonates
Outcome/Application of Research
To be applied to current and future neonates requiring the Intensive Care Unit (ICU)
Publications
Filkins BA, Gregory K, Insoft RM. Comparison of Ibuprofen Lysine Versus Indomethacin For The closure of Patent Ductus Arteriosus [Abstract #430]. Society for Pediatric Research (SPR), Baltimore, MD., May, 2009.
Pantano C, Dodge C, Vanasse M, Insoft, RM. Enhanced Role of NICU Based Respiratory Therapists in an Academic Perinatal Center’s Neonatal Delivery Room Team-The Results of a BWH NICU Quality Improvement Project [Abstract #429]. Society for Pediatric Research (SPR), Baltimore, MD., May, 2009.
Cape A, Insoft RM, Carusi D. Lack of Association Between Neonatal NEC or IVH and in-Utero Indomethacin Exposure, Society of Maternal Fetal Medicine, Chicago, Il., February, 2010, submitted.